StonvexLoading…
StonvexStonvexStonvexCore line items from MGTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.98M | $6.87M | $3.33M | $15.92M |
Operating Income | $-93.31M | $-60.55M | $-31.76M | $-116.36M |
Net Income | $-104.24M | $-29.58M | $-30.36M | $-129.62M |
EPS (Diluted) | $-1.91 | $-1.15 | $-0.62 | $-2.87 |
Total Assets | $267.19M | $310.26M | $288.14M | $318.24M |
Total Liabilities | $175.31M | $186.74M | $197.92M | $200.50M |
Cash & Equivalents | $63.37M | $92.77M | $68.78M | $115.52M |
Free Cash Flow OCF − CapEx | $-107.96M | $-79.98M | $-46.00M | $-118.06M |
Shares Outstanding | 59.60M | 59.54M | 48.48M | 48.48M |